Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Arts, Society & Me.
Press releases published on April 1, 2025
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 1, 2025
CLEVELAND, April 01, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule …
Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D.
GlobeNewswire
·
April 1, 2025
PRINCETON, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs targeted to the tumor microenvironment (TME), today announced …
Military Vehicle Market Size Worth $65.53 Billion, Globally, by 2031 - Exclusive Report by The Insight Partners
GlobeNewswire
·
April 1, 2025
US …
Interactive Entertainment Group Inc. Ranks No. 101 on the 2025 Inc. Regionals: Northeast List, Marking Its Third Appearance
GlobeNewswire
·
April 1, 2025
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- The leading media brand and playbook for entrepreneurs and business leaders shaping the future, today revealed that Interactive Entertainment Group Inc. ranks No. 101 on its fifth annual Inc. Regionals: …
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences
GlobeNewswire
·
April 1, 2025
MINNEAPOLIS, April 01, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that Brian Sullivan, Chief Executive Officer, and Co-founder of …
Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 1, 2025
ALPHARETTA, Ga., April 01, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that George …
Cartesian Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 1, 2025
FREDERICK, Md., April 01, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapies for autoimmune diseases, today announced that its management expects to …
Unicycive Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 1, 2025
LOS ALTOS, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta, M.D., Chief Executive …
Whitestone REIT Announces First Quarter 2025 Earnings Webcast and Conference Call
GlobeNewswire
·
April 1, 2025
HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Whitestone REIT (NYSE:WSR) (“Whitestone” or the “Company”) today announced that it will release its financial results for the first quarter ended March 31, 2025 after the market close on Wednesday, April 30, …
Attralus Presents New Data on Its Pan-Amyloid Diagnostic Candidates at the 2025 American College of Cardiology (ACC) Annual Scientific Session
GlobeNewswire
·
April 1, 2025
124I-evuzamitide (AT-01) PET/CT, the first pan-amyloid diagnostic imaging agent, demonstrated 100% sensitivity and specificity for the diagnosis of cardiac amyloidosis in patients suspected or diagnosed with cardiac amyloidosis in ATTR, AL, and other rare …
Autolus Therapeutics to Host R&D Investor Event on Wednesday, April 23, 2025
GlobeNewswire
·
April 1, 2025
LONDON, April 01, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announced that the Company will …
Medicenna to Present at Jones Healthcare and Technology Innovation Conference
GlobeNewswire
·
April 1, 2025
TORONTO and HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune …
Alamos Gold Provides Notice of First Quarter 2025 Results and Conference Call, and Annual General and Special Meeting of Shareholders
GlobeNewswire
·
April 1, 2025
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) plans to release its first quarter 2025 financial results after market close on Wednesday, April 30, 2025. Senior management will host a conference …
Sysmex’s PA-100 AST System: Revolutionising UTI diagnosis and treatment with precision
GlobeNewswire
·
April 1, 2025
PARIS, April 01, 2025 (GLOBE NEWSWIRE) -- Sysmex’s PA-100 AST System is redefining standard of care for diagnosing and treating urinary tract infections (UTIs). By combining cutting-edge nanofluidic technology with rapid antimicrobial susceptibility …
Le Système PA-100 AST de Sysmex : Révolutionner le diagnostic et le traitement des IU avec précision
GlobeNewswire
·
April 1, 2025
PARIS, 01 avr. 2025 (GLOBE NEWSWIRE) -- Le Système PA-100 AST de Sysmex redéfinit les normes de soins pour le diagnostic et le traitement des infections urinaires (IU). En associant une technologie nanofluidique de pointe à un antibiogramme rapide, le …
Celiac Canada Calls on Federal Politicians to Implement Tax Reform for Gluten-Free Affordability
GlobeNewswire
·
April 1, 2025
Mississauga, ON, April 01, 2025 (GLOBE NEWSWIRE) -- Mississauga, ON. March 26, 2025 – Celiac Canada is urging federal politicians to support a crucial tax policy change that will make life more affordable for the estimated 400,000 Canadians living with …
Planet 13 Announces Grant of RSUs
GlobeNewswire
·
April 1, 2025
LAS VEGAS, April 01, 2025 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, announced that it granted Restricted Stock Units (“RSUs”) to …
15,000 Runners Fuel 2025 Jingdong Suqian Marathon with Passion
GlobeNewswire
·
April 1, 2025
SUQIAN, China, April 01, 2025 (GLOBE NEWSWIRE) -- On March 30, the 2025 Jingdong Suqian Marathon kicked off. A total of 15,000 runners from all over the world gathered to race through the picturesque land of Suqian under the bright spring sun. A Media …
Robotic Process Automation (RPA) Market Disruptions: The $7.9 Billion Opportunity Vendors Can’t Afford to Miss
GlobeNewswire
·
April 1, 2025
Middleton, Massachusetts, April 01, 2025 (GLOBE NEWSWIRE) -- QKS Group, a premier market intelligence and advisory firm, has released its latest in-depth analysis of the global Robotic Process Automation (RPA) Market, providing key insights for industry …
Oculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond
GlobeNewswire
·
April 1, 2025
ZUG, Switzerland, April 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company"), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant …